What Do Hedge Funds See in EMC Corporation?

Data storage provider EMC Corporation (NYSE:EMC) earned a place on our list of the 10 technology stocks hedge funds like for the second quarter of 2012. A total of 51 hedge funds and other notable investors in our database of 13F filers reported a position in the stock. Brookside Capital, a unit of large asset management firm Bain Capital, was one of the funds taking a liking to EMC. Brookside increased its stake in the data storage company, which also provides information security services and intelligence software, by 38% to a total of 9.4 million shares. According to its filing this made EMC one of the top five positions in its portfolio (see more stock picks from Brookside Capital). Another fund with an investment in EMC was billionaire Ken Fisher’s Fisher Asset Management. Fisher owned 22 million shares at the end of June, and the company was one of that fund’s largest holdings as well (check out billionaire Ken Fisher’s favorite stocks).

Ken Fisher - FISHER ASSET MANAGEMENT

In the second quarter of 2012, EMC saw its revenue increase 10% compared to the second quarter of 2011 led by an 18% increase in its smaller services business. Expenses were held down, and one of the largest increases was a 22% increase in spending on R&D. Stripping out net income derived from the company’s stake in VMware, earnings grew 12% to 29 cents per share. Over the first half of the year, revenue was up 10% and net income was up 21% compared to a year ago. Cash flow from operations grew 33%, with the company pulling in $2.9 billion in net cash in the first half of the year; EMC used the cash to pay down some convertible debt and much of the remainder was invested in liquid securities. At the end of June, it reported $4 billion in cash and cash equivalents and $1.7 billion in short-term investments on its balance sheet. However, its current liabilities were fairly high as well and so the company will likely keep much of this liquidity on hand. EMC trades at a trailing price-to-earnings ratio of 23, which places it out of pure value territory but means that it could still be fairly priced if it continues to grow its earnings per share. The sell-side believes that it will, and based on their expectations its forward P/E is 14 and its five-year PEG ratio is just above 1.

The closest peers for EMC are Hewlett-Packard Company (NYSE:HPQ) and International Business Machines Corp. (NYSE:IBM), though these companies have other business interests as well. HP’s stock has fallen 23% in the past year as the company struggles (among other factors, the PC business is being squeezed by tablets), with the stock price correctly anticipating a fall in revenue last quarter compared to a year earlier. The market continues to be skeptical as the stock trades at only 4 times forward earnings estimates. Giant IBM, about four times EMC’s market cap, carries trailing and forward P/E multiples of 15 and 12, respectively. It saw moderate growth in its earnings last quarter, but the effect was entirely due to an increased margin.

We would also compare EMC to fellow data storage-focused companies NetApp Inc. (NASDAQ:NTAP) and Brocade Communications Systems, Inc. (NASDAQ:BRCD). NetApp’s business has been struggling recently: its revenue increased last quarter versus a year ago but its earnings were down. The market expects it to rebound, and its forward P/E is 14 with a trailing P/E of 22. These multiples are similar to EMC’s despite the company’s poorer recent performance. Brocade, a smaller company at a market capitalization of just under $3 billion, trades at a similar trailing multiple (22), but has been growing at a rapid clip and is priced at 11 times forward earnings estimates as it is expected to outperform EMC going forward. Brocade’s growth is tempting if an investor doesn’t have a preference for market leadership, in which case EMC or IBM might be better picks.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

Most Famous Gay Athletes

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!